Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents. 1985

D T Chu, and P B Fernandes, and A K Claiborne, and E Pihuleac, and C W Nordeen, and R E Maleczka, and A G Pernet

A series of novel arylfluoroquinolones has been prepared. These derivatives are characterized by having a fluorine atom at the 6-position, substituted amino groups at the 7-position, and substituted phenyl groups at the 1-position. Structure-activity relationship (SAR) studies indicate that the in vitro antibacterial potency is greatest when the 1-substituent is either p-fluorophenyl or p-hydroxyphenyl and the 7-substituent is either 1-piperazinyl, 4-methyl-1-piperazinyl, or 3-amino-1-pyrrolidinyl. The electronic and spatial properties of the 1-substituent, as well as the steric bulk, play important roles in the antimicrobial potency in this class of antibacterials. As a result of this study, compounds 45 and 41 were found to possess excellent in vitro potency and in vivo efficacy.

UI MeSH Term Description Entries
D007711 Klebsiella pneumoniae Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans. Bacillus pneumoniae,Bacterium pneumoniae crouposae,Hyalococcus pneumoniae,Klebsiella pneumoniae aerogenes,Klebsiella rhinoscleromatis
D009643 Norfloxacin A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE. AM-0715,AM-715,MK-0366,MK-366,MK0366,MK366,Noroxin,AM 0715,AM 715,AM0715,MK 0366,MK 366
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011804 Quinolines
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D004754 Enterobacter Gram-negative gas-producing rods found in feces of humans and other animals, sewage, soil, water, and dairy products.
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005260 Female Females

Related Publications

D T Chu, and P B Fernandes, and A K Claiborne, and E Pihuleac, and C W Nordeen, and R E Maleczka, and A G Pernet
September 1984, Journal of medicinal chemistry,
D T Chu, and P B Fernandes, and A K Claiborne, and E Pihuleac, and C W Nordeen, and R E Maleczka, and A G Pernet
August 2009, Journal of medicinal chemistry,
D T Chu, and P B Fernandes, and A K Claiborne, and E Pihuleac, and C W Nordeen, and R E Maleczka, and A G Pernet
April 1993, Journal of medicinal chemistry,
D T Chu, and P B Fernandes, and A K Claiborne, and E Pihuleac, and C W Nordeen, and R E Maleczka, and A G Pernet
November 1999, Journal of medicinal chemistry,
D T Chu, and P B Fernandes, and A K Claiborne, and E Pihuleac, and C W Nordeen, and R E Maleczka, and A G Pernet
January 2013, Molecules (Basel, Switzerland),
D T Chu, and P B Fernandes, and A K Claiborne, and E Pihuleac, and C W Nordeen, and R E Maleczka, and A G Pernet
December 1995, Chemical & pharmaceutical bulletin,
D T Chu, and P B Fernandes, and A K Claiborne, and E Pihuleac, and C W Nordeen, and R E Maleczka, and A G Pernet
May 1996, Chemical & pharmaceutical bulletin,
D T Chu, and P B Fernandes, and A K Claiborne, and E Pihuleac, and C W Nordeen, and R E Maleczka, and A G Pernet
September 2008, European journal of medicinal chemistry,
D T Chu, and P B Fernandes, and A K Claiborne, and E Pihuleac, and C W Nordeen, and R E Maleczka, and A G Pernet
December 1980, Antimicrobial agents and chemotherapy,
D T Chu, and P B Fernandes, and A K Claiborne, and E Pihuleac, and C W Nordeen, and R E Maleczka, and A G Pernet
January 2009, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!